First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Relationships between the structure of taxol analogs and their antimitotic activity

Françoise Guéritte-Voegelein, Daniel Guénard, François Lavelle et al. · Journal of Medicinal Chemistry · 1991 · 537 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

Frank V. Fossella, J S Lee, Dongjun Shin et al. · Journal of Clinical Oncology · 1995 · 259 citations

Medicine, Oncology, Pharmacology +16

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Frank V. Fossella, J S Lee, William K. Murphy et al. · Journal of Clinical Oncology · 1994 · 223 citations

Medicine, Oncology, Pharmacology +16

Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

Thomas Cerny, Steven Kaplan, N. Pavlidis et al. · British Journal of Cancer · 1994 · 161 citations · Full text

Medicine, Oncology, Pharmacology +10